CLEC4C and coronary artery disorder: Yilmaz et al. assessed the activation status of blood DC precursors and reported a weak expression of costimulatory molecules CD40 and CD86 on circulating BDCA-1+ mDCs or BDCA-2+ pDCs [26], without differences between control and CAD patients.